Bill & Melinda Gates Foundation Archives | Be Korea-savvy
Conagen’s Grant Award Opens New Markets for Monoclonal Antibodies

Conagen’s Grant Award Opens New Markets for Monoclonal Antibodies

Bedford, Mass., March 29 (Korea Bizwire) — The Bill & Melinda Gates Foundation has given a grant to Conagen to support further development of its Conamax(TM) platform for the production of accessible low-cost and high-quality monoclonal antibodies, benefitting developing countries and patients globally. The high cost of monoclonal antibody (mAb) production makes blockbuster drugs expensive, limiting the markets in which these [...]

Bill & Melinda Gates Foundation Invests in S. Korean Companies Developing Virus Vaccine

Bill & Melinda Gates Foundation Invests in S. Korean Companies Developing Virus Vaccine

SEOUL, May 19 (Korea Bizwire) – South Korean companies have received funds from the Bill & Melinda Gates Foundation, one of the world’s largest private foundations, to research treatment for COVID-19 after South Korea became a model case in containing the pandemic, with high potential in the information technology (IT) and biopharma industries. SK Bioscience, a local [...]

KT to Conduct Epidemic Study with Support from Bill & Melinda Gates Foundation

KT to Conduct Epidemic Study with Support from Bill & Melinda Gates Foundation

SEOUL, May 17 (Korea Bizwire) — KT Corp., South Korea’s leading telecommunication firm, said Sunday it will conduct a research project on epidemic prevention with financial support from the Bill & Melinda Gates Foundation. A South Korean consortium led by KT will carry out the project named “A Next Generation Surveillance Study for Epidemic Preparedness,” [...]

Batavia Biosciences Receives $6.5M Grant to Take Next Step Towards Polio-free World

Batavia Biosciences Receives $6.5M Grant to Take Next Step Towards Polio-free World

Leiden, the Netherlands, Sept. 16 (Korea Bizwire) – Today, Batavia Biosciences announces it received a grant of $6.5 million from the Bill & Melinda Gates Foundation to develop a manufacturing process for a novel oral vaccine against polio virus type 2 strain (nOPV2) to help protect children worldwide from future polio outbreaks. In a collaboration with PATH [...]